TIPRL and lung carcinoma: Park et al. displayed that the cAMP signaling pathway regulated by the Epac-Rap1-Akt pathway caused suppression of JNK-dependent HDAC8 degradation, which augments cisplatin-induced apoptosis by inhabiting TIPRL expression in lung cancer cells (33).